Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
about
Cardiac regeneration and diabetesStem cell treatment for acute myocardial infarctionImpact of Timing following Acute Myocardial Infarction on Efficacy and Safety of Bone Marrow Stem Cells Therapy: A Network Meta-AnalysisStem cell therapy for CHD: towards translationAdipose tissue-derived stem cells as a therapeutic tool for cardiovascular diseaseBone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research networkStem cell imaging: from bench to bedsideImpact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysisRegenerative principles enrich cardiac rehabilitation practiceStem cell mechanisms during left ventricular remodeling post-myocardial infarction: Repair and regenerationCardiac Progenitor Cells in Myocardial Infarction Wound Healing: A Critical ReviewHuman iPS Cell-Derived Cardiac Tissue Sheets: a Platform for Cardiac RegenerationStrategy to Prime the Host and Cells to Augment Therapeutic Efficacy of Progenitor Cells for Patients with Myocardial InfarctionThe winding road to regenerating the human heartAdult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled TrialsChallenges in identifying the best source of stem cells for cardiac regeneration therapyIntracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trialFifteen years of bone marrow mononuclear cell therapy in acute myocardial infarctionDetection of intramyocardially injected DiR-labeled mesenchymal stem cells by optical and optoacoustic tomographyCell therapy for cardiac repair--lessons from clinical trials.Tracking of stem cells in vivo for cardiovascular applications.A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis.Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration.Implementation of cardovascular cell therapy network trials: challenges, innovation and lessons learned from experience in the CCTRNStem cell therapy for pediatric dilated cardiomyopathy.Blood vessel repair and regeneration in the ischaemic heartFused X-ray and MR imaging guidance of intrapericardial delivery of microencapsulated human mesenchymal stem cells in immunocompetent swineNew vessel formation in the context of cardiomyocyte regeneration--the role and importance of an adequate perfusing vasculature.Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.MRI-3D ultrasound-X-ray image fusion with electromagnetic tracking for transendocardial therapeutic injections: in-vitro validation and in-vivo feasibility.Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival.Percutaneous Coronary Intervention in Spontaneous Coronary Artery Dissection: Role of Intravascular Ultrasound.A training program in cardiovascular cell-based therapy: from the NHLBI Cardiovascular Cell Therapy Research Network.Clinical trials of cardiac repair with adult bone marrow- derived cells.Strategies for cardiac regeneration and repair.Impact of cell number and microvascular obstruction in patients with bone-marrow derived cell therapy: final results from the randomized, double-blind, placebo controlled intracoronary Stem Cell therapy in patients with Acute Myocardial Infarction (Effect of cell origin and timing of delivery for stem cell-based bone tissue engineering using biologically functionalized hydrogels.The effect of bone marrow mononuclear stem cell therapy on left ventricular function and myocardial perfusion.Human placenta-derived adherent cells improve cardiac performance in mice with chronic heart failure.
P2860
Q21195758-CEE981DB-7291-439A-8A95-9253DDC54B06Q24186920-7A5921E6-FF2F-4986-B517-7B16762B7297Q26771257-BAE4F346-1A49-4AF6-8FEF-5526A8E3EFC4Q26786034-6AE6DCAF-739A-4F9F-8226-6F53497129CBQ26795749-B6C50F42-443C-4FBC-82D5-FCE26D30D850Q26821783-37D17185-99B3-4EC8-A031-CFE8FED4846FQ26861615-566E7B6A-B9AE-4981-990E-00AE4742759CQ27001633-ECEDEC19-2E4C-494F-BBAB-4B56D5BD75FEQ27022906-9807FD6D-0AF3-4FE9-ACAA-1A58B37EAF6CQ27026285-AB142552-B719-4976-97ED-BD49CF25AC69Q27686825-E9FBF7B2-14ED-4A19-A84E-C65D84E82F96Q28077395-E459448F-7A47-4F3A-90E9-E57AC2BD574EQ28077893-17FC0515-CB40-4369-8F83-CD9D1AF90CD2Q28081476-EF5D45BC-396A-4975-98B9-4CD06605AC64Q28082162-BD7A3DA2-0299-4238-926D-2830B12059F9Q28083859-DF0FEA15-787B-421B-95F5-57560F89EEF8Q29620043-E4E8609A-C7CE-4BD0-BFBA-6973F415A1E9Q29994502-60CC099C-30B5-4A65-AFE6-1373C9638195Q30355871-D97EAC93-A5E5-42B5-8829-DCC952CCC9EFQ30359782-DD399CF2-835E-4636-B9CB-B6589535929AQ30443013-D1047703-E174-4DAE-B48A-7E3B30BA51C6Q30541785-B32F4677-C1FA-4560-869D-A11BE79FF329Q30896351-31C70AA4-D374-4DD6-9F20-35490FDDC2B6Q33909634-26C9D47E-6026-484E-AA5A-DC4961BB5530Q33981146-3C8ACDB9-0307-4CE4-85DF-6CB2AA093DA2Q34026311-068B1B8A-D629-4AF9-9069-B53826B609CCQ34304413-9E9DD083-35B8-4675-AB8F-4BD22FE15241Q34343125-30AC3B81-948D-4BE6-8682-178BCCAC8EEDQ34422460-0BF50FA2-A25F-467E-8B11-66787AB09569Q34467911-30FF213E-C6BE-4B11-865C-EFC98709787AQ34546508-09227D24-7EEA-4E9C-A3A4-2F7058037FD8Q34661275-1995380E-81AC-4601-B8CF-35D107BE42F6Q34693128-016B1FF4-E12B-465F-80BC-EFF0B1B45C01Q34729459-99F359ED-2776-41DA-9D1C-F5D3191CAB5DQ34786321-B78DC938-2F17-4C09-BB02-DFABCFDAE830Q34795299-5B75A98F-753E-4067-97D4-3C88A02A7B0DQ34879592-5D991E09-4C8B-4152-9928-D3F27965EB8FQ34983861-60D9077F-EBB4-428B-96B6-1B8E55074985Q35079018-67F23294-ECC0-49F6-86B8-E60D6051B547Q35119685-19ED69D1-6D28-4775-8430-88E5A9E5BA62
P2860
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effect of intracoronary delive ...... the LateTIME randomized trial.
@ast
Effect of intracoronary delive ...... the LateTIME randomized trial.
@en
Effect of intracoronary delive ...... the LateTIME randomized trial.
@nl
type
label
Effect of intracoronary delive ...... the LateTIME randomized trial.
@ast
Effect of intracoronary delive ...... the LateTIME randomized trial.
@en
Effect of intracoronary delive ...... the LateTIME randomized trial.
@nl
prefLabel
Effect of intracoronary delive ...... the LateTIME randomized trial.
@ast
Effect of intracoronary delive ...... the LateTIME randomized trial.
@en
Effect of intracoronary delive ...... the LateTIME randomized trial.
@nl
P2093
P2860
P356
P1476
Effect of intracoronary delive ...... the LateTIME randomized trial.
@en
P2093
Adrian P Gee
Antonis K Hatzopoulos
Barry J Byrne
Beth C Jorgenson
Cardiovascular Cell Therapy ResearchNetwork
Carl J Pepine
Carrie Geither
Catalin Loghin
Charles Lambert
Christopher R Cogle
P2860
P304
P356
10.1001/JAMA.2011.1670
P407
P577
2011-11-14T00:00:00Z